site stats

Biotheranostics portal login

WebJan 6, 2024 · On Monday, it announced acquisition of Somatex Medical for $64 million, a buy also in the women's health space. Hologic's $230 million valuation is roughly seven times the $33 million of revenue Biotheranostics generated in 2024 and roughly six times the revenue range of high $30 million to low $40 million projected for 2024, according to ... WebBiotheranostics is a commercial-stage molecular diagnostics company that support physicians in the treatment of cancer patients. Acquired by Hologic San Diego, California, United States 11-50 Venture - Series Unknown Private www.biotheranostics.com/ 48,677 Highlights Total Funding Amount $32M Contacts 88 Employee Profiles 1 Investors 3

Hologic Completes Acquisition of Biotheranostics, Enters …

WebJan 5, 2024 · Biotheranostics is a leader in the development of evidence-based biomarkers to address unmet medical needs, and the company has set the foundation for rapid growth. For more information, visit... WebJan 5, 2024 · BioTheranostics's latest funding round was a Acquired for on January 5, 2024. BioTheranostics's valuation in January 2016 was $94.01M. BioTheranostics's latest post-money valuation is from January 2024. Sign up for a free trial to see BioTheranostics's valuations in January 2024 and more. sharon gray attorney https://dvbattery.com

BioTheranostics Stock Price, Funding, Valuation, Revenue

WebFeb 22, 2024 · MARLBOROUGH, Mass.-- (BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics, Inc. … WebWelcome to the Diagnostic Portal! This portal provides Adaptive clinical customers with the ability to: Fill out a Test Requisition Form (which must be printed, signed by the ordering … WebNot Registered? Click here to start the process.. Loading population sydney australia

Breast Cancer Index Hologic

Category:BioTheranostics Company Profile: Acquisition & Investors

Tags:Biotheranostics portal login

Biotheranostics portal login

CancerTYPE ID Hologic

WebBeing part of Hologic only helps bring that hope closer to reality. In addition, patients facing the challenges of metastatic cancer will have broader access to our CancerTYPE ID offering that can aid in the diagnosis of the tumor type and subtypes representing 95% of all solid tumors.”. Both of Biotheranostics’ tests are PCR (polymerase ... WebThis test is used for clinical purposes, and should not be regarded as experimental or investigational. How this information is used to guide patient care is the responsibility of …

Biotheranostics portal login

Did you know?

WebLogin NeoGenomics News 3/17/23 MGMT Promoter Methylation Analysis Temporary Send-Out: Effective immediately, MGMT Promoter Methylation Analysis performed on FFPE tissue is sent out to ARUP for processing. This change applies to both the stand-alone test and the molecular add-on in the NeoTYPE DNA & RNA – Brain Profile . WebBiotheranostics, Inc. has been acquired by Hologic. Hologic is an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. …

WebProvider Portal Patient Payment Portal Biotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to … WebBiotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients. …

WebProvider Portal Patient Payment Portal Biotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to … Biotheranostics, Inc. (BTX) complies with applicable Federal civil rights laws and … WebJan 5, 2024 · Biotheranostics is a leader in the development of evidence-based biomarkers to address unmet medical needs, and the company has set the foundation for rapid growth. For more information, visit biotheranostics.com . Non-GAAP Financial Measures This press release discusses non-GAAP diluted EPS, which is a non-GAAP …

WebBiotheranostics Inc Is this Your Business? Business Profile Biotheranostics Inc Medical Lab Contact Information 9640 Towne Centre Dr #200 San Diego, CA 92121 Visit Website Email this Business...

population table worldWebMar 15, 2007 · Biotheranostics, Inc. is a provider established in San Diego, California operating as a Clinical Medical Laboratory. The NPI number of this provider is 1043344435 and was assigned on March 2007. The practitioner's primary taxonomy code is 291U00000X with license number CLIA 05D1065725 (CA). sharon graves facebookWebBiotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients. It offers CancerTYPE ID, a gene expression test for metastatic patients with diagnostic ambiguity, and Breast Cancer Index, a tool for breast cancer patients. Type sharon gravelle rhode islandWebFeb 22, 2024 · Biotheranostics also developed and markets the CancerTYPE ID test, which provides a molecular diagnosis for patients with uncertain or unknown cancers. In advanced cancer that has metastasized, it ... sharon gray obeWebApr 19, 2024 · Biotheranostics Inc. has agreed to pay $2 million to resolve allegations that it submitted and caused the submission of false claims to Medicare for Breast Cancer Index (BCI) tests that were not reasonable and necessary for the diagnosis and treatment of breast cancer, the Department of Justice announced today. Biotheranostics is a … sharon graves blvd kitchenWebSign-in for online ordering (iStore), product documentation library, or online medical education and training. population syracuse nyWebSep 21, 2024 · Biotheranostics, Inc., is a leading healthcare provider in the oncology field assisting physicians in the treatment of cancer patients. Its suite of commercially … population tadcaster